Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single Cell RNA Sequencing
Split Biosciences, now Parse Biosciences, Announces $7M in Series A Funding to Democratize Single Cell RNA Sequencing Share Article As adoption of scRNA-seq in industry and academia accelerates, Parse Biosciences (formerly Split Bio) offers the most flexible and scalable single cell sequencing kit, no custom instrument needed Parse Biosciences In addition to increased scalability, Parse Biosciences’s technology also provides researchers with higher data quality. Parse enables researchers to increase gene detection in individual cells, while dramatically reducing confounding artifacts that a...
Source: prweb.com